Jacobs Levy Equity Management
TIL icon

Jacobs Levy Equity Management’s Instil Bio TIL Stock Holding History

Jacobs Levy Equity Management’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$331K Buy
+43,051
New +$347K ﹤0.01% 873
2023
Q4 		– Sell
-43,364
Closed -$371K – 1080
2023
Q3 		$371K Buy
43,364
+32,677
+306% +$329K ﹤0.01% 852
2023
Q2 		$118K Buy
+10,687
New +$131K ﹤0.01% 943

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $14.6M AUM 63.08% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Jacobs Levy Equity Management's TIL Position: Q2 2026 in Review

Jacobs Levy Equity Management opened a new position in Instil Bio (TIL) in Q2 2026: 43,051 shares worth $331K. The stake represents ﹤0.01% of the portfolio and ranks #873 among its holdings. This is a return to the name: Jacobs Levy Equity Management previously reported a position in TIL as recently as Q3 2023.

Jacobs Levy Equity Management first reported a position in TIL in Q2 2023 and has held it in 3 quarters since. The position peaked at $371K in Q3 2023. 26 funds tracked by Wall St. Rank hold TIL as of Q2 2026.

  • Jacobs Levy Equity Management held 43,051 shares of Instil Bio worth $331K as of Q2 2026.
  • Instil Bio was a new Jacobs Levy Equity Management position in Q2 2026.
  • Instil Bio made up ﹤0.01% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #873 holding.
  • Jacobs Levy Equity Management first reported a position in Instil Bio in Q2 2023 and has held it in 3 quarters since.
  • Jacobs Levy Equity Management's Instil Bio position peaked at $371K in Q3 2023.
  • 26 funds tracked by Wall St. Rank held Instil Bio as of Q2 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.